ResultsIQ

ResultsIQ › Latest results › Vishnu Chemicals Limited

Vishnu Chemicals Limited Q2 FY26 results deck summary

NSE: VISHNU · BSE: 516072

Results deck of 10 Nov 2025, summarised by AI from the filing.

Vishnu Chemicals reported record Q2FY26 revenue of ₹401.1 cr, up 16.7% y-o-y, with PAT up 44.0% to ₹32.8 cr.

Key takeaways

  1. Profit Q2FY26 PAT rose 44.0% y-o-y to ₹32.8 cr and EBITDA rose 28.8% to ₹58.2 cr.
  2. Exports Export revenues grew 30% q-o-q from ₹157 cr in Q1FY26 to ₹205 cr in Q2FY26.
  3. New plant Commercial production of Strontium Carbonate began at Vizag, commissioned in Q2FY26.
  4. Risk Management noted the performance came despite a challenging environment.

Original filing on BSE

Vishnu Chemicals Limited Q1 FY27 results

As filed: Revenue ₹433 cr (+25% year on year), EBITDA ₹65.5 cr (+19% year on year), PAT ₹39.6 cr (+24% year on year), EBITDA margin 15.1% (−74 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹450 cr (+15% year on year), EBITDA ₹76.7 cr (+22% year on year), PAT ₹43.4 cr (+11% year on year), EBITDA margin 17.0% (+100 bps). Score 56 of 100, In line with trend. Revenue and profit growth were in line with the company's own trend; EBITDA growth was above it. EBITDA margin rose 100 bps year on year. Share price after the results: +4.2% in 30 days (Nifty 500: +1.5%).
  • Q3 FY26: Revenue ₹411 cr (+11% year on year), EBITDA ₹61.7 cr (−2% year on year), PAT ₹33.8 cr (−1% year on year), EBITDA margin 15.0% (−197 bps). Score 43 of 100, In line with trend. Revenue growth was in line with the company's own trend; EBITDA and profit growth were below it. EBITDA margin fell 197 bps year on year. Share price after the results: −1.4% in 30 days (Nifty 500: −1.1%).
  • Q2 FY26: Revenue ₹401 cr (+17% year on year), EBITDA ₹59.0 cr (+31% year on year), PAT ₹33.0 cr (+43% year on year), EBITDA margin 14.7% (+163 bps). Score 81 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA and profit growth were well above it. EBITDA margin rose 163 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Revenue rose ₹57.0 cr on a year ago, more than the ₹36.0 cr it added the year before. Share price after the results: −1.1% in 29 days (Nifty 500: +1.4%).
  • Q1 FY26: Revenue ₹347 cr (+2% year on year), EBITDA ₹55.0 cr (0% year on year), PAT ₹32.0 cr (+7% year on year), EBITDA margin 15.9% (−37 bps). Score 40 of 100, Below trend. Revenue growth was below the company's own trend; EBITDA and profit growth were in line with it. EBITDA margin fell 37 bps year on year. Consolidated profit +7% but standalone -31%. Revenue fell 12% from last quarter. Share price after the results: −9.0% in 30 days (Nifty 500: +0.2%).
  • Q4 FY25: Revenue ₹393 cr (+31% year on year), EBITDA ₹63.0 cr (−2% year on year), PAT ₹39.0 cr (+39% year on year), EBITDA margin 16.0% (−530 bps). Score 56 of 100, In line with trend. Revenue and profit growth were well above the company's own trend; EBITDA growth was below it. EBITDA margin fell 530 bps year on year. Consolidated profit +39% but standalone -35%. Share price after the results: +18.6% in 29 days (Nifty 500: +0.5%).
  • Q3 FY25: Revenue ₹371 cr (+22% year on year), EBITDA ₹63.0 cr (+54% year on year), PAT ₹34.0 cr (+62% year on year), EBITDA margin 17.0% (+349 bps). Score 86 of 100, Above trend. Revenue, EBITDA and profit growth were well above the company's own trend. EBITDA margin rose 349 bps year on year. Consolidated profit +62% but standalone +0%.
  • Q2 FY25: Revenue ₹344 cr (+12% year on year), EBITDA ₹45.0 cr (−2% year on year), PAT ₹23.0 cr (−4% year on year), EBITDA margin 13.1% (−185 bps). Score 35 of 100, Below trend. EBITDA margin fell 185 bps year on year. Not enough history for a trend yet: scored on growth alone. Profit fell 23% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Vishnu Chemicals Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.